WELLS FARGO & COMPANY/MN - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$215,519
-40.4%
3,712
-44.7%
0.00%
Q2 2023$361,577
+150.6%
6,717
+84.9%
0.00%
Q1 2023$144,302
+289.9%
3,633
+294.9%
0.00%
Q4 2022$37,011
-9.7%
920
-29.2%
0.00%
Q3 2022$41,000
-46.1%
1,300
-49.6%
0.00%
Q2 2022$76,000
-67.4%
2,580
-68.8%
0.00%
Q1 2022$233,000
-74.3%
8,275
-57.9%
0.00%
Q4 2021$907,000
+58.8%
19,668
+13.0%
0.00%
Q3 2021$571,000
-23.4%
17,404
-18.2%
0.00%
Q2 2021$745,000
-21.7%
21,269
-19.3%
0.00%
Q1 2021$952,000
-8.0%
26,361
-26.1%
0.00%
Q4 2020$1,035,000
-28.8%
35,664
-30.7%
0.00%
Q3 2020$1,454,000
-15.8%
51,500
-3.5%
0.00%
-100.0%
Q2 2020$1,727,000
+19.2%
53,387
+50.1%
0.00%0.0%
Q1 2020$1,449,000
-72.8%
35,571
-58.8%
0.00%0.0%
Q4 2019$5,330,000
-35.6%
86,428
-23.9%
0.00%
-50.0%
Q3 2019$8,274,000
+68.6%
113,538
+90.3%
0.00%
+100.0%
Q2 2019$4,907,000
+110.5%
59,678
+80.6%
0.00%0.0%
Q1 2019$2,331,000
+73.3%
33,039
+10.5%
0.00%
Q4 2018$1,345,000
-21.8%
29,887
-1.7%
0.00%
Q3 2018$1,719,000
+55.7%
30,392
+84.0%
0.00%
Q2 2018$1,104,000
+37.8%
16,515
+19.9%
0.00%
Q1 2018$801,000
-8.6%
13,774
+1.4%
0.00%
Q4 2017$876,000
+49.0%
13,588
+21.2%
0.00%
Q3 2017$588,000
-21.8%
11,215
-30.2%
0.00%
Q2 2017$752,000
+72.1%
16,058
+81.8%
0.00%
Q1 2017$437,000
-56.1%
8,832
-46.2%
0.00%
Q4 2016$995,000
+80.6%
16,416
+97.8%
0.00%
Q3 2016$551,000
+90.0%
8,298
+59.4%
0.00%
Q2 2016$290,000
-20.5%
5,206
-52.1%
0.00%
Q1 2016$365,0000.0%10,871
+34.2%
0.00%
Q4 2015$365,000
-96.1%
8,098
-96.6%
0.00%
-100.0%
Q3 2015$9,320,000
-32.2%
235,894
+6.5%
0.00%
-20.0%
Q2 2015$13,743,000
-53.7%
221,500
-53.4%
0.01%
-16.7%
Q1 2015$29,704,000
+58.7%
474,904
+43.1%
0.01%
-14.3%
Q4 2014$18,714,000
+173.9%
331,864
+37.4%
0.01%
+133.3%
Q3 2014$6,833,000
+42.2%
241,606
+73.1%
0.00%
+50.0%
Q2 2014$4,806,000
+5690.4%
139,544
+5173.8%
0.00%
Q1 2014$83,0002,646
+88100.0%
0.00%
Q3 2013$030.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders